GABAergic drugs for the treatment of migraine

CNS and Neurological Disorders - Drug Targets

Volumn 6, Issue 4, 2007, Pages 247-250

  Puppe, Anja ^a   Limmroth, Volker ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

GABA transaminase; Gabapentin; Pregabalin; Topiramate; Valproic acid

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ANALGESIC AGENT; ANTIMIGRAINE AGENT; BACLOFEN; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; DIHYDROERGOTAMINE; GABAERGIC RECEPTOR AFFECTING AGENT; GABAPENTIN; ION CHANNEL; LYSINE ACETYLSALICYLATE; METOCLOPRAMIDE; NEUROSTEROID; PLACEBO; PREGABALIN; PROCHLORPERAZINE; PROGESTERONE; PROGESTERONE DERIVATIVE; PROPRANOLOL; TOPIRAMATE; VALPROIC ACID;

ANALGESIC ACTIVITY; ANTINOCICEPTION; BINDING SITE; BRAIN CORTEX; BRAIN STEM; CHANNELOPATHY; CLINICAL TRIAL; DRUG MECHANISM; DRUG TARGETING; DRUG TOLERABILITY; DRUG USE; EPILEPSY; EXCITABILITY; HUMAN; MIGRAINE; NEUROPATHIC PAIN; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; SPASTICITY; SPREADING CORTICAL DEPRESSION; UNSPECIFIED SIDE EFFECT;

ACUTE DISEASE; AMINES; ANIMALS; CYCLOHEXANECARBOXYLIC ACIDS; FRUCTOSE; GABA AGENTS; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; HUMANS; MIGRAINE DISORDERS; NEUROPROTECTIVE AGENTS; RECEPTORS, GABA; RECEPTORS, GABA-A; RECEPTORS, GABA-B; VALPROIC ACID;

EID: 34547735439     PISSN: 18715273     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152707781387305     Document Type: Review

References (44)

1. Dawson, G.R.; Collinson, N.; Atack, J.R. CNS Spectr., 2005, 10, 21.
2. Farrar, S.J.; Whiting, P.J.; Bonnert, T.P.; McKernan, R.M. J. Biol. Chem., 1999, 274,10100.
3. McKernan, R.M.; Whiting, P.J. Trends Neurosci., 1996, 4,139.
4. Chou, K.C. Biochem. Biophys. Res. Commun., 2004, 316, 636.
5. Farrant M, Nusser Z. Nat. Rev. Neurosci., 2005, 3, 215.
6. Paul, S.M.; Purdy, R.H. FASEB J., 1992, 6, 2311.
7. Blakie, N.H.; Hossack, J.C. Canad. Med. Ass. J., 1932, 27, 45.
8. Bradley, W.G.; Hudgson, J.B.; Poster, J.B.; Newell, D.J. Br. Med. J., 1968, 3, 531.
9. Limmroth, V. Pain, 1996, 67, 513.
10. Bowery, N.G.; Doble, A.; Hill, D.R.; Hudson, A.L.; Shaw, J.S.; Turnbull, M.J.; Warrington, R. Eur. J. Pharmacol., 1981, 71, 53.
11. Franek, M.; Vaculin, S.; Rokyta, R. Physiol. Res., 2004, 53, 351-355.
12. Addolorato, G.; Leggio, L.; Agabio, R.; Colombo, G.; Gasbarrini, G. Int. J. Clin. Pract., 2006, 60, 1003-1008.
13. Helm, K.A.; Haberman, R.P.; Dean, S.L.; Hoyt, E.C,; Melcher, T.; Lund, P.K.; Gallagher, M. Neuropharmacology, 2005, 48, 956-964.
14. Johannessen, C.U. Neurochem. Int., 2000, 37, 103.
15. Cutrer, F.M.;, Limmroth, V.; Moskowitz, M.A. Cephalgia, 1997, 17(2), 93.
16. Lee, W.S.; Limmroth, V.; Ayata, C.; Cutrer, F.M.; Waeber, C.; Yu, X.; Moskowitz, M.A. British J. Pharmacol., 1995, 116, 1661.
17. Cutrer, F.M.; Limmroth, V.; Ayata, G.; Moskowitz, M.A. Br. J. Pharmacol., 1995, 116, 3199.
18. Hering, R.; Kuritzky, A. Cephalalgia, 1992, 12, 81.
19. Jensen, R.; Brinck, T.; Olesen, J. Neurology, 1994, 44, 647.
20. Yoon, M.S.; Savidou, I.; Diener, H.C.; Limmroth, V. Exp. Rev. Neurotherapeutics, 2005, 5, 333.
21. White, H.S. Headache, 2005, 45(Suppl 1), S48.
22. Wauquier, A.; Zouh, S. Epilepsy Res., 1996, 24, 73.
23. Coulter, D.A.; Sombati, S.; DeLorenzo, R.J. Epilepsia, 1993, 34(Suppl 2),123.
24. Zhang, X.; Velumian, A.A.; Jones, O.T.; Carlen, P.L. Epilepsia, 1998, 39(Suppl 6), 44.
25. Zhang, X.; Velumian, A.A.; Jones, O.T.; Carlen, P.L. Epilepsia, 2000, 41(Suppl 1), S30.
26. Shank R.P.; Gardocki, J.F.; Vaught, J.L.; Davis, C.B.; Schupsky, J.J.; Ratta, R.B.; Dodgson, S.J.; Nortey, S.O.; Maryanoff, B.E. Epilepsia, 1994, 35(Suppl 2), 450.
27. Dodgson, S.J.; Shank, R.P.; Maryanoff, B.E. Epilepsia, 2000, 41(Suppl 1), S35.
28. Edwards, K.R.; Potter, D.L.; Wu, S.C.; Kamin, M,.; Hulihan, J. CNS Spectr., 2003, 8, 428.
29. Martinez, H.R.; Londono, O.; Cantu-Martinez, L.; del Carmen Tarin, L.; Castillo, C.D. Headache, 2003, 43, 1080.
30. Brandes, J.L.; Saper, J.R. Diamond, M.; Couch, J.R.; Lewis, D.W.; Schmitt, J.; Neto, W.; Schwabe, S.; Jacobs, D: JAMA, 2004, 291, 965.
31. Silberstein, S.D. Headache, 2005, 45 (Suppl 1), S57.
32. Diener, H.C.; Tfelt-Hansen, P.; Dahlof, C.; Lainez, M.; Sandrini, G.; Wang, S.S.; Neto, W.; Vijapurkar, U.; Doyle, A.; Jacobs, D. J. Neurol., 2004, 251, 943.
33. Fehrenbacher, J.C; Taylor, C.P; Vasko, M.R. Pain, 2003, 105, 133.
34. Sills, G.J. Curr. Opin. Pharm., 2006, 6, 108.
35. Bian, F.; Li Z.; Offord, J.; Davis, M.D.; McCormick, J.; Taylor, C.; Walker, C. Brain Res., 2006, 23, 1075, 68.
36. Di Trapani, G.; Mei, D.; Marra, C.; Mazza, S.; Capuano, A. Clin. Ter., 2000, 15, 145.
37. Mathew, N.T.; Rapoport, A.; Saper, J.; Magnus, L.; Klapper, S.; Ramadan, N.; Stacey, B.; Tepper, S. Headache, 2001, 41, 119.
38. Storer, R.J.; Akerman, S.; Shields, K.G.; Goadsby, P.J. Brain Res., 2004, 1013, 188.
39. Limmroth, V.; Lee, W.S.; Moskowitz, M.A. Br. J. Pharmacol., 1996, 117, 99.
40. Mathew, N.T.; Kailasam, J.; Meadors, L.; Chemyschev, P.; Gentry, P. Headache, 2000, 40, 720.
41. Stillman, M.J.; Zajac, D.; Rybicki, L.A. Headache, 2004, 44, 65.
42. Edward, K.R.; Norton, J.; Behnke, M. Headache, 2001, 41, 976.
43. Tanen, D.A.; Miller, S.; French, T.; Riffenbourgh, R.H. Ann. Emerg. Med., 2003, 41, 847.
44. Leniger, T.; Pageler, L.; Stude, P.; Diener, H.C.; Limmroth, V. Headache, 2005, 45, 1.